The incidence of "Postreperfusion syndrome" in adult living donor liver transplantations [Canli vericiden karaciger transplantasyonlari sirasinda Postreperfüzyon sendromu i·nsidansi]

The acute hemodynamic deterioration at the beginning of reperfusion period during liver transplantations is called as the "Postreperfusion syndrome" (PRS) and is described as more than 30% decrease in mean arterial blood pressure lasting longer than one minute during the first five minutes after reperfusion. It isfor this reason that we aimed to retrospectively the PRS incidence and evaluate its treatment during the 50 living donor liver transplantations performed in our institution under general anesthesia. PRS was seen in 23 of 50 (46%) patients. Treatment for PRS was not needed in two of these. For the treated 21 patients the dose of ephedrine needed was 27.5 mg mean (SD: ±16.2; range: 7.5-75 mg). In conclusion, the PRS is seen during living donor liver transplantations in nearly half of the patients without being predicted previously. Thus, before reperfusion precautions for the PRS must be taken peroperatively; prompt diagnosis of the typical hemodynamic effects of the PRS by appropriate monitoring and immediate treatment are necessary.